What does CUSIP 37890U908 represent in this 13F holders report?

CUSIP 37890U908 is the security identifier for 37890U908 - GLOBAL BLOOD THERAPEUTICS IN - CALL used to aggregate holder disclosures.

How many institutions held 37890U908 - GLOBAL BLOOD THERAPEUTICS IN - CALL in Q4 2022?

No institutional holders were reported for 37890U908 - GLOBAL BLOOD THERAPEUTICS IN - CALL in Q4 2022; review adjacent reporting periods for trend context.

GLOBAL BLOOD THERAPEUTICS IN - CALL

CUSIP: 37890U908

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / CALL
Total 13F shares: 0
Share change: -255,800
Total reported value: $0
Number of holders: 0
Value change: -$17,420,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 37890U908?
CUSIP 37890U908 identifies 37890U908 - GLOBAL BLOOD THERAPEUTICS IN - CALL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2022

Recent filing periods for CUSIP 37890U908:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

GLOBAL BLOOD THERAPEUTICS IN - CALL

Q4 2022 13F Holders as of 31 Dec 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of GLOBAL BLOOD THERAPEUTICS IN - CALL as of Q4 2022.